These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 12073051)

  • 21. Detection of occult bone metastases of lung cancer with fluorine-18 fluorodeoxyglucose positron emission tomography.
    Foo SS; Ramdave S; Berlangieri SU; Scott AM
    Australas Radiol; 2004 Jun; 48(2):214-6. PubMed ID: 15230758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
    Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
    Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
    Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
    J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[
    Sonni I; Minamimoto R; Baratto L; Gambhir SS; Loening AM; Vasanawala SS; Iagaru A
    Mol Imaging Biol; 2020 Apr; 22(2):397-406. PubMed ID: 31236756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of hormone receptor status in comparison of 18F -FDG-PET/CT and 99mTc-MDP bone scintigraphy for evaluating bone metastases in patients with breast cancer: single center experience.
    Teke F; Teke M; Inal A; Kaplan MA; Kucukoner M; Aksu R; Urakci Z; Tasdemir B; Isikdogan A
    Asian Pac J Cancer Prev; 2015; 16(1):387-91. PubMed ID: 25640386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential diagnosis between secondary and tertiary hyperparathyroidism in a case of a giant-cell and brown tumor containing mass. Findings by (99m)Tc-MDP, (18)F-FDG PET/CT and (99m)Tc-MIBI scans.
    Gedik GK; Ata O; Karabagli P; Sari O
    Hell J Nucl Med; 2014; 17(3):214-7. PubMed ID: 25397627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer.
    Abe K; Sasaki M; Kuwabara Y; Koga H; Baba S; Hayashi K; Takahashi N; Honda H
    Ann Nucl Med; 2005 Oct; 19(7):573-9. PubMed ID: 16363622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
    Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
    Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
    Iagaru A; Mittra E; Dick DW; Gambhir SS
    Mol Imaging Biol; 2012 Apr; 14(2):252-9. PubMed ID: 21479710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
    Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK
    J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of 18F-FDG PET-directed skeletal biopsy for metastatic neoplasm.
    Pezeshk P; Sadow CA; Winalski CS; Lang PK; Ready JE; Carrino JA
    Acad Radiol; 2006 Aug; 13(8):1011-5. PubMed ID: 16843854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
    Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M
    Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Earlier detection of bone metastases from pleomorphic liposarcoma in a pediatric patient by FDG PET/CT than planar 99mTc MDP bone scan.
    Yang J; Codreanu I; Servaes S; Zhuang H
    Clin Nucl Med; 2012 May; 37(5):e104-7. PubMed ID: 22475918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.
    Damle NA; Bal C; Bandopadhyaya GP; Kumar L; Kumar P; Malhotra A; Lata S
    Jpn J Radiol; 2013 Apr; 31(4):262-9. PubMed ID: 23377765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of fluorodeoxyglucose-positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    J Comput Assist Tomogr; 2007; 31(5):812-9. PubMed ID: 17895798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
    Cook GJ; Houston S; Rubens R; Maisey MN; Fogelman I
    J Clin Oncol; 1998 Oct; 16(10):3375-9. PubMed ID: 9779715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer.
    Uematsu T; Yuen S; Yukisawa S; Aramaki T; Morimoto N; Endo M; Furukawa H; Uchida Y; Watanabe J
    AJR Am J Roentgenol; 2005 Apr; 184(4):1266-73. PubMed ID: 15788608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomography and bone metastases.
    Fogelman I; Cook G; Israel O; Van der Wall H
    Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer.
    Bury T; Barreto A; Daenen F; Barthelemy N; Ghaye B; Rigo P
    Eur J Nucl Med; 1998 Sep; 25(9):1244-7. PubMed ID: 9724372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.